# Intra-tumor Injection of Oncolytic Viruses H101 Combined With or Without Radiotherapy in Refractory/Recurrent Gynecological Malignancies

> **NCT05051696** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Liu Zi** · enrollment: 120 (actual)

## Conditions studied

- Genital Neoplasms, Female

## Interventions

- **DRUG:** H101

## Key facts

- **NCT ID:** NCT05051696
- **Lead sponsor:** Liu Zi
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-09-26
- **Primary completion:** 2024-03-30
- **Final completion:** 2025-03-30
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2024-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05051696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05051696, "Intra-tumor Injection of Oncolytic Viruses H101 Combined With or Without Radiotherapy in Refractory/Recurrent Gynecological Malignancies". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05051696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*